TrialAntimicrobial agents and chemotherapy2026

Phase I studies assessing safety and pharmacokinetics of nacubactam administered alone or in combination with cefepime or aztreonam in Japanese healthy participants.

Jun Morita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.